Approval · Notice of Compliance 12005 · 2011
CLONIDINE: Notice of Compliance 12005
Issued January 17, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12005
- Date
- January 17, 2011
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Vascular stabilizer for the treatment of menopausal flushing (0.025 mg tablet) / Antihypertensive (0.1 and 0.2 mg tablets)
Products in this notice
Medicinal ingredients
- CLONIDINE HYDROCHLORIDE 0.025 MG per TAB
- CLONIDINE HYDROCHLORIDE 0.1 MG per TAB
- CLONIDINE HYDROCHLORIDE 0.2 MG per TAB